How accurate is SPECT thallium scintigraphy?  by Diamond, George A.
lACC Vol. 16, NO.4
October 1990: 1017-21
EDITORIAL REVIEWS
How Accurate Is SPECT Thallium Scintigraphy?*
GEORGE A. DIAMOND, MD, FACC
Los Angeles, California
1017
Iskandrian et al. (1) recently reported a specificity of only
62% for exerciselredistribution thallium-201 single photon
emission computed tomography (SPECT) among patients
undergoing coronary angiography within 6 months of the
scintigraphic test. In their circumspect discussion of this
troubling observation, the authors suggest that the low
specificity might be explained by referral bias-a preferential
selection of positive test responders for angiographic verifi-
cation, resulting in a higher prevalence of disease in this
group undergoing catheterization-and they cite the 93%
"normalcy rate" among patients not undergoing catheteriza-
tion with <5% probability of coronary artery disease in
support of this argument. But they go on to say that the
disease prevalence and sensitivity observed in their study
are inconsistent with this explanation and conclude that
"these two viewpoints ... cannot be reconciled."
In an accompanying editorial comment, Gould (2) cor-
rectly notes that the observation of low specificity is not at
issue, only its explanation. He therefore uses Bayes' theo-
rem to reanalyze the data and concludes that referral bias
does not explain the reported observations and that the
specificity of the test is very close to the 62% value reported
by Iskandrian et al. (1). Gould then claims that the sensitivity
and specificity of positron emission tomography (PET) are
both 95% (although he fails to note that these figures are
based on an unconventional-albeit justifiable-functional
standard, rather than the usual anatomic standard used by
Iskandrian et al.), and claims further that the greater accu-
racy of PET versus SPECT has "major economic benefits,"
Sensitivity and specificity versus predictive accuracy of a
test. Unfortunately, all these conclusions are suspect be-
cause both authors committed the common error of confus-
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ing sensitivity and specificity [the probability of the test
response (R) given disease status (S), p(RIS)] with predictive
accuracy [the probability of disease status given the test
response, p(SIR)]. For example, according to Iskandrian et
al. (I),
... a posttest probability of 62% for a normal coronary
arteriogram as reported in our study requires a pretest
prevalence of disease of 85% ... ,
and according to Gould (2),
If the observed post-test probability of disease for a normal
noninvasive test is 50% in a study population. the appar-
ent specificity in the study population would be 50% (with
50% having a false positive result).
Each of these statements is wrong, Instead, Bayes'
theorem defines the correct relation between these so-called
inverse conditional probabilities: p(SIR) x p(R) = p(RIS) x
p(S). Consequently, the graph of post-test probability (pre-
dictive accuracy) versus pretest probability (prevalence) that
Iskandrian et al. (I) and Gould (2) rely on for their analyses
is completely inappropriate to assess the variability of sen-
sitivity and specificity, because this format considers sensi-
tivity and specificity to be invariant by definition with
respect to predictive accuracy and prevalence.
Effect of referral bias. Accordingly, I will show that
referral bias alone does indeed provide a consistent expla-
nation for these confusing observations, will derive esti-
mates of sensitivity and specificity for SPECT after correct-
ing for this bias and will compare these values to those from
other studies.
Let me illustrate the effect of referral bias on the observed
sensitivity and specificity of a test with a simple example.
Assume you have a diagnostic test for coronary artery
disease with a sensitivity of 50% and a specificity of 99%.
Assume further that you rely on this test (your reasons are
not important) in such a way that you refer each and every
patient with a positive test response to angiography
(p = I), but you never refer a patient with a negative test
response to angiography (q = 0). Because only positive test
responders will undergo angiography, every patient with
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Table 1. A Conventional Binary Matrix of Test Performance
Disease Status
Abnormal Normal
~c: Positive TP FP0
5;-
<lJ...
to Negative FN TN
<lJ
E-
FN = number of false negatives; FP = number of false positives: TN =
number of true negatives; TP = number of true positives.
disease will have an abnormal test response (observed
sensitivity 100%), but so will every patient without disease
(observed specificity 0%). This simple example illustrates
the degree to which referral bias can affect the observed
sensitivity and specificity of a test. If you only perform
catheterization on patients with a positive test response,
sensitivity appears very good, whereas specificity appears
very bad.
Conventional binary matrix of test performance. Let me
generalize this example. Suppose we perform a diagnostic
test on a group of patients and refer everyone of these
patients for diagnostic verification. We can thereby classify
the test responses according to the 2 x 2 matrix illustrated in
Table 1, and calculate the conventional indexes of test
performance as follows:
Sensitivity = True positives/(True positives +False negatives)
= TP/(TP + FN)
Specificity = True negatives/(False positives + True negatives)
= TN/(FP + TN)
Positive predictive accuracy = TP/(TP + FP)
Negative predictive accuracy = TN/(FN + TN)
However, if we happen to refer only the proportion p of
all the patients with a positive test response and the propor-
tion q of all the patients with a negative test response for
diagnostic verification, we can thereby classify only a por-
tion of the data (that summarized in Table 2), and will
therefore calculate a somewhat different set of indexes:
Table 2. Effect of Referral Bias on Observed Performance
Disease Status
Abnormal Normal
<lJ
'" Positive TP x p FP x pc:
0
5;-
~
'" Negative
FN x q TN x q
<lJ
E-
p = proportion of positive test responders referred for diagnostic verifi-
cation; q = proportion of negative test responders referred for diagnostic
verification; other abbreviations as in Table l. p and q can be conditioned on
the observed test response. but they cannot be conditioned on disease status.
because disease status is still unknown at the time of testmg.
Observed sensitivity = TP x p/(TP x p + FN x q)
Observed specificity = TN x q/(FP x p + TN x q)
Observed positive predictive accuracy =
TP x p/(TP x p + FP x p) TP/(TP + FP)
Observed negative predictive accuracy =
TN x q/(FN x q + TN x q) = TN/(FN + TN)
According to these equations, if p and q are not equal-
that is, if the proportion of patients referred for diagnostic
verification depends in some way on the test response (and
isn't that what a test is for?)-the observed sensitivity and
specificity are not the same as the actual sensitivity and
specificity. Predictive accuracy, on the other hand, is not
affected by this so-called referral bias.
The study of Iskandrian et at. (I), Let us apply these
insights to the data reported by Iskandrian et al. 0). First,
27% of the patients in this study did not undergo angio-
graphic verification of disease status. Instead, the investiga-
tors assumed that these patients were normal because they
had a <5% probability of disease (lskandrian et al. do not
say if this assessment was based on a formal calculation or a
subjective judgment), and substituted the frequency of neg-
ative tests among this "low likelihood" group (the "normal-
cy rate") as an unbiased estimate of the actual specificity of
the test. I have criticized this highly arbitrary approach more
fully elsewhere (3,4) and will not repeat my arguments here.
As an aside, however, if this so-called normalcy rate is really
a suitable substitute for specificity, why not then employ a
symmetrically high probability of 95% to define the "abnor-
malcy rate" as an analogous substitute for sensitivity? But
what then about all the patients who fall between these
extremes-those for whom diagnostic testing is really in-
tended?
I maintain that the "low likelihood" expedient and its
attendant "normalcy rate" have no place in modern tech-
nology assessment so long as better methods are available to
adjust biased estimates of sensitivity and specificity (5,6).
Such methods exploit the entire population of patients
referred for testing (5-9), rather than only the select group
referred for diagnostic verification or those with an arbitrar-
ily low probability of disease. I recently published (7) a
computer algorithm, for example, that takes advantage of
the fact that predictive accuracy is not affected by referral
bias (6,8), and thereby adjusts observed values of sensitivity
and specificity for referral bias given knowledge of the total
number of patients referred for testing, the total number of
positive test responses. and the number of true positives,
false positives, true negatives and false negatives in the
subset referred for angiography. Before reanalyzing the
SPECT data with this algorithm, however, let us more
closely examine some particular sources of bias in this study
group.
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Table 3. Thallium Scintigraphy and the Diagnosis of Coronary Artery Disease
Total Total Total Angiographic Referrals
Patients Positive Negative
Laboratory Tested Tests Tests Total TP FP TN FN
Los Angeles (LA) 1.845 1.055 790 248 183 31 16 18
Philadelphia (Phila) 2.455 1.404 1.051 330 224 22 36 48
(as reported) (1)
Philadelphia 2.038 1.166 872 274 174 19 33 48
(excluding MI) (1)
Values for the total number of patients tested and the total number of positive and negative tests in Philadelphia are estimated from the proportions observed
in Los Angeles. An example for the Philadelphia data (as reported) is shown below:
248 Total angiographic referrals (LA)
1.845 Total patients tested (LA)
1.055 Total positive tests (LA)
1.845 Total patients tested (LA)
330 Total angiographic referrals (Phila)
2.455 Total patients tested (Phila)
1.404 Total positive tests (Phila)
2.455 Total patients tested (Phila)
MI = myocardial infarction on the electrocardiogram: other abbreviations as in Table 1.
Sources of bias in the study of Iskandrian et at. (1).
Iskandrian et al. (1) were properly concerned about the
effect of referral bias on test specificity, but they were not
equally concerned about its effect on sensitivity. Thus,
although the inclusion of patients with previous myocardial
infarction is known to inflate test sensitivity (4,5), 47% of the
patients in this study had a history of infarction, and 17% had
electrocardiographic (ECG) evidence of myocardial infarc-
tion (50 patients with and 6 without disease on angiography).
Because the report of Iskandrian et al. focuses on the
diagnosis of coronary artery disease (rather than on the
detection of ischemia), and because the diagnosis of coro-
nary artery disease is not at issue in patients with myocardial
infarction, these patients should have been excluded from
their analysis.
Fortunately, test responses for the 50 patients with dis-
ease who had ECG evidence of myocardial infarction were
reported separately (1); when we exclude these patients,
sensitivity decreases slightly from 82% to 78%. Although,
test responses for the six normal patients with myocardial
infarction by ECG were not reported separately, we can still
perform a best case and a worst case analysis. With the
assumption that all six patients had positive test responses,
specificity increases from 62% (36 of 58) to 69% (36 of 52)
after their exclusion, and with the assumption that all six
patients had negative test responses, specificity decreases to
58% (30 of 52) after their exclusion. Because this range is
small, I shall assume that three of the six patients had a
positive response. This results in a specificity of 63% (33 of
52) after their exclusion.
Table 3 summarizes the data required to correct the
observed sensitivity and specificity for referral bias. The first
row of data represents a previously reported (7) analysis of
planar thallium scintigraphy among Los Angeles patients
without previous myocardial infarction. The second row of
data is for the current Philadelphia study (1) as originally
reported (before exclusion of the 56 patients with myocardial
infarction by ECG); and the third row of data excludes the 56
Philadelphia patients with myocardial infarction by ECG.
The total number of positive and negative test responders
was not reported by Iskandrian et al. (1). I therefore esti-
mated these values by assuming that the proportion of
patients with positive test responses and the proportion of
patients referred for angiography in Los Angeles (l,055 of
1,845 [57%] and 248 of 1,845 [13%], respectively) are iden-
tical to the proportions observed in Philadelphia (l,404 of
2,455 [57%] and 330 of 2,455 [13%], respectively). The
calculations are detailed in the legend to Table 3.
Table 4 shows the proportion of positive and negative test
responders referred for coronary angiography for each study
group and the ratio between these proportions. In each case,
referral bias is indicated by a significantly higher proportion
of positive responders than negative responders being re-
ferred for angiography (p > q). The ratio between p and q
serves as a formal operative definition of referral bias and a
quantitative index of its magnitude. Thus, the 5:1 ratio
between p and q in Los Angeles versus the 2: 1 ratio in
Philadelphia indicates significantly greater referral bias in the
Los Angeles laboratory (p < 0.001).
Figure 1 illustrates the corrected true positive (sensitivi-
ty) and false positive rate (1 - specificity) for SPECT as a
function of the proportion of positive test responses in the
total group of patients undergoing testing in a given labora-
tory (7). Three general conclusions derive directly from this
graph: 1) the data are consistent with a true sensitivity of
80% and a true specificity of 60% (similar to the values
observed in the angiographically studied patients from Phil-
adelphia) if and only if the unreported frequency of positive
test responses averages 73% in Philadelphia; 2) the data are
consistent with a true specificity of 90% (similar to the
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Table 4. Proportion of Positive and Negative Thallium Scintigraphic Test Responders Referred to Coronary Angiography
Total Patients Angiographie Referrals
Positive Negative Positive Negative p(%) q(%) p/q ratio
Laboratory Tests (a) Tests (b) Tests (e) Tests (d) (e/a) (d/b) (be/ad)
Los Angeles 1.055 790 214 34 20 4 4,7 ± 0,8
Philadelphia 1.404* 1.051* 246 84 18* 8* 2,2 ± OJ*
(as reported) (I)
Philadelphia 1.166* 872* 193 81 17* 9* 1.8 ± 0,2*
(excluding Mil (I)
*Conditioned on the proportions observed in Los Angeles (see Table 3), p represents the number of angiographie referrals with positive tests divided by the
total number of positive tests: q represents the number of angiographie referrals with negative tests divided by the total number of negative tests: other
abbreviations as in Tables 2 and 3,
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cise results" (12). This is not correct. The study was indeed
influenced by referral bias because the investigators (2) say
Figure 1. The relation between the frequency of a positive test in a
study group undergoing diagnostic testing in a given laboratory
[p(R)] (x axis) and the frequency of a positive test conditioned on
disease status among those referred for angiography [p(RIS)] (y
axis). The illustrated curves are for single photon emission com-
puted tomography (SPECT) thallium imaging based on data reported
by Iskandrian et al. (I). after excluding 56 patients with known
myocardial infarction by electrocardiogram and correcting for refer-
ral bias (7). The upper curve is derived from patients with coronary
artery disease (CAD) and therefore represents the true positive rate
(or sensitivity) of the test. The lower curve is derived from patients
without coronary artery disease (No CAD) and therefore represents
the false positive rate (or I - specificity) of the test. The two
superimposed data points represent the true and false positive rate
for planar thallium imaging in patients without previous myocardial
infarction after similarly correcting for referral bias (7). The vertical
bars associated with these points represent 95% confidence intervals
for these estimates. Although this graph appears similar to the plot
of pretest probability (prevalence) versus post-test probability (pre-
dictive accuracy) used by Gould (2). its interpretation is entirely
different. The data illustrated here are consistent with the conclu-
sion that any observed difference in sensitivity and specificity
between SPECT and planar imaging is explainable by referral bias.
observed "normalcy rate" in Philadelphia) if and only if the
true sensitivity averages 42% and the frequency of positive
responses averages 32%; and 3) the data are inconsistent
with Gould's assertion (2) that the true sensitivity and
specificity are both 65%. According to the graph, if sensitiv-
ity is 65%, then specificity must be 77% and the frequency of
positive responses must be 55%. In contrast, if specificity is
65%, then sensitivity must be 77% and the frequency of
positive responses must be 69%. We can't have it both ways.
Table 5 summarizes the sensitivity and specificity of
thallium scintigraphy before and after correction for referral
bias. Each sensitivity is significantly lower, and each speci-
ficity is significantly higher (using Fisher's exact test) after
correction for referral bias. Thus, although the observed
sensitivities and specificities in Los Angeles and Philadel-
phia are very different, the corrected sensitivities and spec-
ificities are very similar.
Tomographic versus conventional planar thallium imaging.
According to this reassessment, then, the accuracy of tomo-
graphic imaging is surprisingly similar to that for conven-
tional planar imaging after correcting for the inappropriate
inclusion in the study group of postinfarction patients and
"normal" subjects not undergoing catheterization, and the
preferential referral of positive test responders to angiogra-
phy. Although others 00, II) have concluded that diagnostic
SPECT imaging is superior to planar imaging, their studies
contained a substantial degree of referral bias as well. In one
of these studies (10), 8 (53%) of the 15 patients with disease
had previous myocardial infarction, and 17 (81%) of the 21
patients without disease were in the "low likelihood" group
of patients not undergoing catheterization. In the other study
(1), 77 (80%) of the 96 patients with disease had previous
myocardial infarction and 23 (59%) of the 39 patients without
disease were normal volunteers, not undergoing catheteriza-
tion, with a low probability of coronary artery disease.
Gould (2) cites a recent study (2) that reported a 76%
sensitivity and a 49% specificity for planar thallium scintig-
raphy among asymptomatic young men in support of his
contention that the low specificity of the test is not explained
by referral bias, because he says all subjects were referred
for coronary angiography"... regardless of thallium exer-
lACC Vol. 16. No.4
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Table 5. Accuracy of Thallium Scintigraphy for Diagnosis of
Angiographic Coronary Artery Disease Before and After
Correction for Referral Bias
Sensitivity (±I SO) (%) Specificity (±I SO) (o/r;)
Laboratory Observed Corrected Observed Corrected
Los Angeles 91 ± 2 68 ± 4 34 ± 7 71 ± 5
Philadelphia 82 ± 2 68 ± 2* 62 ± 6 78 ± 4*
(as reported) (1)
Philadelphia 78 ± 3 67 ± 2* 63 ± 7 76 ± 5*
(excluding MIl (1)
*Conditioned on the proportions observed in Los Angeles (see Table 3).
The corrected sensitivity and specificity are calculated from the raw data
presented in Table 3with use of a previously published computer algorithm (7)
based on Bayes' theorem: p(R!S) = p(SIR) x p(R)/p(Sl, where p(RIS) is the
probability of the positive test response given disease. p(SIR) is the probability
of disease given the positive test response. p(R) is the overall proportion of
positive test responses and piS) is the prior probability of disease. Proportion
of positive tests [p(R)] = Total positive tests/Total patients tested = (TP +
FP)/(TP + FP + TN + FN); Positive predictive accuracy (PPA) = True
positives/(True positives + False positives) = TP/(TP + FP): Negative
predictive accuracy (NPA) = False negatives/(True negatives + False nega-
tives = FN/(TN + FN). Corrected sensitivity =PPA x p(R)/{PPA x p(R) +
NPA[I - p(R)]}: Corrected specificity = I - II - PPA) x p(Rl/[(1 - PPAl x
p(R) + (1 - NPA)(1 - p(Rl]. Other abbreviations as in Table 3.
they included all subjects " ... undergoing coronary angi-
ography because of abnormal noninvasive tests suggesting
silent myocardial ischemia." Accordingly, if the overall
frequency of positive thallium tests in this low prevalence
study group were 30% (half of that in our high prevalence
symptomatic study group), then the data in this study are
consistent with a corrected specificity of 74% (significantly
higher than the observed value of 49% and similar to the
corrected values in Table 5) and a corrected sensitivity of
51% (significantly lower than the observed values in Table
5). The lower sensitivity and similar specificity are just what
one might expect given the lesser severity of disease (fewer
diseased vessels and milder degree of narrowing) in asymp-
tomatic individuals compared with asymptomatic patients.
Conclusions. Perhaps most important of all, this reassess-
ment indicates how hard it is to determine the accuracy of
our diagnostic tests, especially after they have diffused into
routine clinical practice (13-17). Just as Bayes' theorem tells
us that the predictive accuracy of a test is conditioned on the
prevalence of disease in the study group tested. it also tells
us that the observed sensitivity and specificity of that test are
conditioned on the magnitude of bias introduced by the
assessment process itself. As a result, a test will perform "as
advertised" only if it is applied to patients similar to those in
whom it was first assessed.
We must therefore continue to develop better methods of
analyzing and reporting the results of these assessment
studies-and we must be encouraged to use them. Until
then, I urge investigators to adopt the simple convention of
reporting not only the sensitivity and specificity they just
happen to observe in a relatively small, select group of
angiographic referrals, but the frequency and number of
positive test responses in the larger group of nonangio-
graphic referrals as well. And I urge clinicians to view with
caution any sensitivity or specificity derived from reports
that do not include such information. What you see ain't
always what you get!
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